Year: 2017
Type: article
Abstract: The 18 kDa translocator protein TSPO localizes on the outer mitochondrial membrane (OMM). Systematically overexpressed at sites of neuroinflammation it is adopted as a biomarker of brain conditions. TSPO inhibits the autophagic removal of mitochondria by limiting PARK2-mediated mitochondrial ubiquitination via a peri-organelle accumulation of reactive oxygen species (ROS). Here we describe that TSPO deregulates mitochondrial Ca 2+ signaling leading to a parallel increase in the cytosolic Ca 2+ pools that activate the Ca 2+ -dependent NADPH oxidase (NOX) thereby increasing ROS. The inhibition of mitochondrial Ca 2+ uptake by TSPO is a consequence of the phosphorylation of the voltage-dependent anion channel (VDAC1) by the protein kinase A (PKA), which is recruited to the mitochondria, in complex with the Acyl-CoA binding domain containing 3 (ACBD3). Notably, the neurotransmitter glutamate, which contributes neuronal toxicity in age-dependent conditions, triggers this TSPO-dependent mechanism of cell signaling leading to cellular demise. TSPO is therefore proposed as a novel OMM-based pathway to control intracellular Ca 2+ dynamics and redox transients in neuronal cytotoxicity.
Source: Cell Death and Disease
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,990
Awards: Therapeutic targeting of stromal NOX4-derived ROS signaling in prostatic disease, PET Methodology, G6632427627, G7020990049, Focusing on the mitochondrial expression of TSPO as a marker and promoter of neuroinflammation, Role of the mitochondrial Translocator Protein (mTSPO) in cell homeostasis: a molecular pathway in signalling and self-conservation mechanisms, PET Call: Development Of Quantitative CNS PET Imaging Probes For The Glutamate and GABA Systems
OpenAlex ID: W2723023976
